Systemic Insulin-like Growth Factor-1 Reverses Hypoalgesia and Improves Mobility in a Mouse Model of Diabetic Peripheral NeuropathyDiabetic peripheral neuropathy (DPN) is a complication resulting in sensory and motor neuron damage that affects 50% of diabetic patients.
...more »